Abbott Laboratories (ABT)
104.09
-0.78
(-0.74%)
USD |
NYSE |
May 17, 16:00
104.01
-0.08
(-0.08%)
After-Hours: 20:00
Abbott Laboratories Cash from Operations (Annual): 7.261B for Dec. 31, 2023
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 7.261B |
December 31, 2022 | 9.581B |
December 31, 2021 | 10.53B |
December 31, 2020 | 7.901B |
December 31, 2019 | 6.136B |
December 31, 2018 | 6.30B |
December 31, 2017 | 5.57B |
December 31, 2016 | 3.203B |
December 31, 2015 | 2.966B |
December 31, 2014 | 3.675B |
December 31, 2013 | 3.324B |
December 31, 2012 | 9.314B |
December 31, 2011 | 8.97B |
December 31, 2010 | 8.736B |
December 31, 2009 | 7.275B |
December 31, 2008 | 6.995B |
December 31, 2007 | 5.184B |
December 31, 2006 | 5.329B |
Date | Value |
---|---|
December 31, 2005 | 5.174B |
December 31, 2004 | 4.467B |
December 31, 2003 | 3.553B |
December 31, 2002 | 3.992B |
December 31, 2001 | 3.567B |
December 31, 2000 | 3.100B |
December 31, 1999 | 2.938B |
December 31, 1998 | 2.780B |
December 31, 1997 | 2.660B |
December 31, 1996 | 2.382B |
December 31, 1995 | 1.966B |
December 31, 1994 | 2.212B |
December 31, 1993 | 1.847B |
December 31, 1992 | 1.389B |
December 31, 1991 | 1.453B |
December 31, 1990 | 1.201B |
December 31, 1989 | 959.90M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
6.136B
Minimum
2019
10.53B
Maximum
2021
8.282B
Average
7.901B
Median
2020
Cash from Operations (Annual) Benchmarks
Stryker Corp | 3.711B |
Boston Scientific Corp | 2.503B |
Intuitive Surgical Inc | 1.814B |
Edwards Lifesciences Corp | 895.80M |
Insulet Corp | 145.70M |